Press release
SACHS 3482083150 LuK 143028820 430MM SAAB SCANIA CLUTCH COVER
Unmatched Performance for Heavy-Duty Vehicles
Designed for SAAB and SCANIA applications, this clutch cover is a perfect fit for vehicles requiring superior durability and strength. The 430MM diameter ensures compatibility with a wide range of heavy-duty trucks and buses, offering consistent performance under challenging driving conditions.
Why Choose the SACHS and LuK Clutch Cover?
* Exceptional Build Quality Manufactured using high-grade materials, the clutch cover is resistant to wear and tear, providing a long service life even in demanding environments.
* OE Standard Assurance With OE numbers 3482083150 (SACHS) and 143028820 (LuK), this clutch cover meets or exceeds original equipment specifications, ensuring seamless integration into your vehicle's existing system.
* Enhanced Driving Safety By delivering smooth and reliable power transmission, the clutch cover contributes to better vehicle control and driver safety, especially during long hauls or under heavy loads.
Applications and Compatibility
This clutch cover is specifically engineered for SAAB and SCANIA heavy-duty vehicles. Before purchasing, confirm your vehicle's compatibility using the OE numbers: 3482083150 or 143028820.
Why Buy from Terbon Auto Parts?
At Yancheng Terbon Auto Parts Co., Ltd., we are committed to providing top-quality auto parts for the automotive industry. Our products undergo rigorous testing to ensure they meet the highest performance standards. Whether you're looking for brake pads, clutch kits, or other essential components, you can count on us for reliable solutions.
Order Your SACHS 3482083150 LuK 143028820 Clutch Cover Today!
Don't compromise on safety or performance. Click here [https://www.terbonparts.com/sachs-3482083150-luk-143028820-430mm-saab-scania-clutch-cover-product/] to learn more and place your order today.
Media Contact
Company Name: Yancheng Terbon Auto Parts Co., Limited
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=sachs-3482083150-luk-143028820-430mm-saab-scania-clutch-cover]
Country: China
Website: https://www.terbonparts.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release SACHS 3482083150 LuK 143028820 430MM SAAB SCANIA CLUTCH COVER here
News-ID: 3790373 • Views: …
More Releases from ABNewswire
Alcohol Use Disorder Pipeline 2026: Latest FDA Approvals, Clinical Trials, and E …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, Alcohol Use Disorder pipeline constitutes 30+ key companies continuously working towards developing 30+ Alcohol Use Disorder treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Alcohol Use Disorder Pipeline Insight, 2026" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Alcohol Use Disorder Market.
The…
Muscle Invasive Bladder Cancer Market: Pharma Pipeline Fuels Rapid Expansion by …
The Key Muscle Invasive Bladder Cancer Companies in the market include - CG Oncology, Pfizer, UroGen Pharma, Janssen Research & Development, LLC, Protara Therapeutics, Binhui Biopharmaceutical, SURGE Therapeutics, Pfizer, AstraZeneca, ImmunityBio, Inc., Guarionex J. Decastro, Janssen Research & Development, Tollys, Aura Biosciences, Vaxiion Therapeutics, Incyte Corporation, Janssen Pharmaceuticals, Theralase Technologies, BristolMyers Squibb, Asieris Pharmaceuticals, and others.
DelveInsight's "Muscle Invasive Bladder Cancer Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth…
Curiva Med Spa Unveils XERF Technology in Beverly Hills, California: A New Era o …
Curiva Med Spa in Beverly Hills debuts XERF, a zero-downtime lifting tech, partnering with Cynosure Lutronic. Led by Tamara Yang DNP and Amar Hirani MBA, the clinic combines Ivy League medical rigor with luxury hospitality. With an expert nursing team and Visia 7 data-driven analysis, this sanctuary at the Beverly Hills Plaza Hotel has organically built a loyal following including celebrities and influencers.
BEVERLY HILLS, Calif. - Partnering with global leader…
Playwise HQ Launches HubSpot Integration to Sync Deals and Competitive Win/Loss …
Playwise HQ has launched a HubSpot CRM integration that syncs Deals and win/loss outcomes between HubSpot and Playwise HQ. Sales teams can capture primary and secondary win/loss reasons, detailed deal feedback, and competitor-specific insights directly from closed opportunities. This ensures competitor battlecards show a complete history of deals won and lost, helping reps identify patterns, improve positioning, and keep competitive intelligence consistent across both platforms.
SYDNEY, Australia - 19 February, 2026…
More Releases for SACHS
Mississippi Businesswoman Accepted into Goldman Sachs Cohort Program
Executive Coach Candie L. Simmons has been selected to join the prestigious Goldman Sachs One Million Black Women cohort program, a significant initiative to drive economic opportunity for Black women. Goldman Sachs One Million Black Women is a $10 billion investment commitment with $100 million in philanthropic capital to drive economic opportunity for one million Black women by 2030. One Million Black Women is a first-of-its-kind comprehensive investment focused on…
Tay Sachs Disease Market Size, Report and Forecast 2024-2032
The Tay Sachs disease market size was valued at USD 2.3 billion in 2023, driven by the increasing investment in the domain across the major markets. The market size is anticipated to grow at a CAGR of 5.6% during the forecast period of 2024-2032 to achieve a value of USD 3.83 billion by 2032.
Tay Sachs Disease: Introduction
Tay-Sachs disease is a rare, inherited neurodegenerative disorder. It's caused by the absence of…
Goldman Sachs Wealth Management Report- Competitor Profile
This competitor profile provides a comprehensive analysis of Goldman Sachs' private banking and wealth management operations. It offers insight into the company's strategy and financial performance, including key data on assets under management. Customer targeting, service proposition, product innovation, and marketing activities are also covered.
Single User License: US $ 1295
Purchase this Report @ https://www.marketreportsonline.com/contacts/purchase.php?name=836340
Goldman Sachs is one of the leading financial services companies globally, with a presence in 29 locations.…
Tay-Sachs Disease Therapeutics- Pipeline Analysis 2018, Clinical Trials & Result …
Tay-Sachs is a lysosomal storage disorder caused by the deficiency of vital enzymes called beta-hexosaminidase A (Hex-A). The role of Hex-A is to degrade a fatty substance or lipid called GM-2 ganglioside. In the absence of the Hex-A enzymes, GM-2 accumulates abnormally in cells, especially in the nerve cells or neurons, of the brain.
Download the sample report @ https://www.pharmaproff.com/request-sample/1107
In children, the destructive process begins in the fetus early in pregnancy.…
Volunteers from Goldman Sachs Visit Treloars Disabled School
Nineteen workers from the London office of the global organisation visited the College on 1st July to transform the entrance to the site into a feast of greenery.
Project Leader, Nic Hobbs, admitted spending the day gardening was a far cry from his usual tasks as a Project Manager in the Technology Division at Goldman Sachs.
He explained: "Goldman Sachs employees spend a day every year doing some sort of community based…
AAA, Goldman Sachs Upgrade Fibria Celulose to BUY Rating
Analysts have issued a research note to investors today, 4 April 2011, announcing that they have upgraded shares in Fibria Celulose S.A. (NYSE: FBR) to "buy".
Boston, Mass, April 06, 2011 -- Analysts have issued a research note to investors today, 4 April 2011, announcing that they have upgraded shares in Fibria Celulose S.A. (NYSE: FBR) to "buy".
Goldman Sachs had previously upgraded the eucalyptus firm’s stocks to "neutral" from "underweight" earlier…
